Sort
39,280 grants matching “leukemia”
RAG-mediated DNA Damage Responses in Immune Development and Function
$514,846Jeffrey J Bednarski · Washington University · R01 · FY2022 · AI
Molecular Studies of Bone Marrow Failure
$514,833Monica Bessler · Washington University · R01 · FY2007 · CA
Control Of G Protein Signaling: Role Of The RGSs
$514,781John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Gvl mHA Specific T Cell Responses Prevent AML Relapse Following Allogeneic Stem Cell Transplantation
$514,741Benjamin G Vincent · Univ Of North Carolina Chapel Hill · R37 · FY2023 · CA
Nanoscale Encasement and Targeted Delivery of Multifunctional Therapeutic Agents
$514,683Thomas V O'Halloran · Northwestern University At Chicago · U54 · FY2009 · CA
Screening for Resistant Enteric Bacteria to Personalize Infection Prevention Strategies in Neutropenic Patients
$514,678Michael Joseph Satlin · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AI
RNA Helicase Mutations in Myelodysplastic Syndrome: New Therapeutic Target
$514,645Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · R01 · FY2015 · HL
RNA Helicase Mutations in Myelodysplastic Syndrome: New Therapeutic Target
$514,645Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · R01 · FY2017 · HL
RNA Helicase Mutations in Myelodysplastic Syndrome: New Therapeutic Target
$514,645Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · R01 · FY2018 · HL
RNA Helicase Mutations in Myelodysplastic Syndrome: New Therapeutic Target
$514,645Jaroslaw P Maciejewski · Cleveland Clinic Lerner Com-Cwru · R01 · FY2016 · HL
Developing and credentialing patient-derived xenograft models to advance therapeutic approaches for chronic myelomonocytic leukemia
$514,636Eric Padron · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2019 · CA
Using spatial, single-cell genomic recording to investigate age-associated clonal hematopoiesis
$514,635Rong Lu · University Of Southern California · R01 · FY2025 · AG
Cancer Genetics of Short Telomere Syndromes
$514,604Mary Y. Armanios · Johns Hopkins University · R01 · FY2019 · CA
Dysregulation of Innate Lymphoid Immunity in Acute Myeloid Leukemia
$514,434Bethany Mundy-Bosse · Ohio State University · R01 · FY2021 · CA
Targeting the Epigenome for Lung Cancer Therapy
$514,430David Schrump · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Dual inhibition of MDM2 and XIAP as a therapeutic strategy in cancer
$514,428Wei Li · University Of Tennessee Health Sci Ctr · R01 · FY2024 · CA
Targeting ABL kinases to regulate epithelial cell plasticity and regeneration following injury
$514,395Ann Marie Pendergast · Duke University · R01 · FY2022 · HL
Therapeutic targeting of growth factor receptors to treat Mucormycosis
$514,361Vincent Michael Bruno · University Of Maryland Baltimore · R01 · FY2021 · AI
Therapeutic targeting of growth factor receptors to treat Mucormycosis
$514,361Vincent Michael Bruno · University Of Maryland Baltimore · R01 · FY2020 · AI
Cyclin Dependent Kinases as Epigenetic Therapy Targets
$514,307Jean-Pierre J Issa · Coriell Institute For Medical Research · P50 · FY2024 · CA
A novel strategy for transcriptional reprogramming of lymphoid leukemia cells
$514,253Bruno Calabretta · Thomas Jefferson University · R01 · FY2024 · CA
Genomics of Treatment -Related Acute Myelogenous Leukemia: Susceptibility Factors
$514,236Timothy A Graubert · Washington University · P01 · FY2012 · CA
The role of N6-methyladenosine RNA modification in programmed and aberrant DNA mutagenesis in B cells
$514,190Uttiya Basu · Columbia University Health Sciences · R01 · FY2020 · AI
Development of Novel PROTACs Targeting the ENL YEATS Domain for Treating MLL-rearranged Leukemias
$514,092Jian Jin · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA
Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing
$514,090Bingliang Fang · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA